AKT1 and Miscarriage: Quantitative in vitro and in vivo experiments, involving the treatment of cultured endothelial progenitor cells with soluble Flt1, demonstrated a reduction in the frequency of miscarriage through the VEGF-PI3K/Akt-endothelial nitric oxide synthase pathway in a mouse recurrent miscarriage model [110].